Literature DB >> 11837721

Efficacy of early immunosuppressive therapy in a child with carbamazepine-associated vanishing bile duct and Stevens-Johnson syndromes.

Monica Garcia1, Maroun J Mhanna, Moon-Ja Chung-Park, Pamela H Davis, Maya D Srivastava.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11837721     DOI： 10.1023/a:1013296310944

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  12 in total

Review 1.  Vanishing bile duct syndrome.

Authors:  P Burra; E Elias
Journal:  Br J Surg       Date:  1992-07       Impact factor: 6.939

2.  Localization of perforin in viral vesicles and erythema multiforme.

Authors:  K Sayama; Y Watanabe; M Tohyama; Y Miki
Journal:  Dermatology       Date:  1994       Impact factor: 5.366

Review 3.  Vanishing bile duct syndrome in drug-induced liver disease.

Authors:  V J Desmet
Journal:  J Hepatol       Date:  1997       Impact factor: 25.083

4.  Vanishing bile duct syndrome occurring after carbamazepine administration: a second case report.

Authors:  C de Galoscy; Y Horsmans; J Rahier; A P Geubel
Journal:  J Clin Gastroenterol       Date:  1994-10       Impact factor: 3.062

5.  Epidermal apoptotic cell death in erythema multiforme and Stevens-Johnson syndrome. Contribution of perforin-positive cell infiltration.

Authors:  S Inachi; H Mizutani; M Shimizu
Journal:  Arch Dermatol       Date:  1997-07

6.  Carbamazepine hepatotoxicity: another cause of the vanishing bile duct syndrome.

Authors:  G M Forbes; G P Jeffrey; K B Shilkin; W D Reed
Journal:  Gastroenterology       Date:  1992-04       Impact factor: 22.682

7.  Detection of an autoantibody directed against human liver microsomal protein in a patient with carbamazepine hypersensitivity.

Authors:  M Pirmohamed; N R Kitteringham; A M Breckenridge; B K Park
Journal:  Br J Clin Pharmacol       Date:  1992-02       Impact factor: 4.335

8.  Drug-associated acute-onset vanishing bile duct and Stevens-Johnson syndromes in a child.

Authors:  M Srivastava; A Perez-Atayde; M M Jonas
Journal:  Gastroenterology       Date:  1998-09       Impact factor: 22.682

9.  Drug-induced prolonged cholestasis in adults: a histological semiquantitative study demonstrating progressive ductopenia.

Authors:  C Degott; G Feldmann; D Larrey; A M Durand-Schneider; D Grange; J P Machayekhi; A Moreau; F Potet; J P Benhamou
Journal:  Hepatology       Date:  1992-02       Impact factor: 17.425

10.  Circulating intercellular adhesion molecule-1 (ICAM-1) in autoimmune liver disease and evidence for the production of ICAM-1 by cytokine-stimulated human hepatocytes.

Authors:  A W Thomson; S Satoh; A K Nüssler; K Tamura; J Woo; J Gavaler; D H van Thiel
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330
View more
  6 in total

1.  Vanishing bile duct and Stevens-Johnson syndrome associated with ciprofloxacin treated with tacrolimus.

Authors:  Gokhan Okan; Serpil Yaylaci; Onder Peker; Sabahattin Kaymakoglu; Murat Saruc
Journal:  World J Gastroenterol       Date:  2008-08-07       Impact factor: 5.742

Review 2.  Infliximab/Plasmapheresis in vanishing bile duct syndrome secondary to toxic epidermal necrolysis.

Authors:  Jason C White; Stephanie Appleman
Journal:  Pediatrics       Date:  2014-09-22       Impact factor: 7.124

Review 3.  Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Authors:  Marianne Lerch; Carlo Mainetti; Benedetta Terziroli Beretta-Piccoli; Thomas Harr
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 10.817

4.  Ibuprofen associated acute vanishing bile duct syndrome and toxic epidermal necrolysis in an infant.

Authors:  Hye-young Kim; Hea Kyoung Yang; Seong Heon Kim; Jae Hong Park
Journal:  Yonsei Med J       Date:  2014-04-01       Impact factor: 2.759

5.  Clinical Features and Treatment Outcomes among Children with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A 20-Year Study in a Tertiary Referral Hospital.

Authors:  Susheera Chatproedprai; Vanvara Wutticharoenwong; Therdpong Tempark; Siriwan Wananukul
Journal:  Dermatol Res Pract       Date:  2018-05-07

6.  Urosodeoxycholic Acid Therapy in a Child with Trimethoprim-Sulfamethoxazole-induced Vanishing Bile Duct Syndrome.

Authors:  Hyun Jeong Cho; Hye Jeong Jwa; Kyu Seon Kim; Dae Yong Gang; Jae Young Kim
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2013-12-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.